Departments of1Neurological Surgery.
2Department of Neurosurgery, Columbia-Presbyterian Medical Center, New York, New York.
Neurosurg Focus. 2018 Apr;44(4):E7. doi: 10.3171/2018.1.FOCUS17734.
OBJECTIVE Anterior skull base meningiomas are benign lesions that cause neurological symptoms through mass effect on adjacent neurovascular structures. While traditional transcranial approaches have proven to be effective at removing these tumors, minimally invasive approaches that involve using an endoscope offer the possibility of reducing brain and nerve retraction, minimizing incision size, and speeding patient recovery; however, appropriate case selection and results in large series are lacking. METHODS The authors developed an algorithm for selecting a supraorbital keyhole minicraniotomy (SKM) for olfactory groove meningiomas or an expanded endoscopic endonasal approach (EEA) for tuberculum sella (TS) or planum sphenoidale (PS) meningiomas based on the presence or absence of olfaction and the anatomical extent of the tumor. Where neither approach is appropriate, a standard transcranial approach is utilized. The authors describe rates of gross-total resection (GTR), olfactory outcomes, and visual outcomes, as well as complications, for 7 subgroups of patients. Exceptions to the algorithm are also discussed. RESULTS The series of 57 patients harbored 57 anterior skull base meningiomas; the mean tumor volume was 14.7 ± 15.4 cm (range 2.2-66.1 cm), and the mean follow-up duration was 42.2 ± 37.1 months (range 2-144 months). Of 19 patients with olfactory groove meningiomas, 10 had preserved olfaction and underwent SKM, and preservation of olfaction in was seen in 60%. Of 9 patients who presented without olfaction, 8 had cribriform plate invasion and underwent combined SKM and EEA (n = 3), bifrontal craniotomy (n = 3), or EEA (n = 2), and one patient without both olfaction and cribriform plate invasion underwent SKM. GTR was achieved in 94.7%. Of 38 TS/PS meningiomas, 36 of the lesions were treated according to the algorithm. Of these 36 meningiomas, 30 were treated by EEA and 6 by craniotomy. GTR was achieved in 97.2%, with no visual deterioration and one CSF leak that resolved by placement of a lumbar drain. Two patients with tumors that, based on the algorithm, were not amenable to an EEA underwent EEA nonetheless: one had GTR and the other had a residual tumor that was followed and removed via craniotomy 9 years later. CONCLUSIONS Utilizing a simple algorithm aimed at preserving olfaction and vision and based on maximizing use of minimally invasive approaches and selective use of transcranial approaches, the authors found that excellent outcomes can be achieved for anterior skull base meningiomas.
目的
前颅底脑膜瘤是一种良性病变,通过对邻近神经血管结构的占位效应引起神经症状。虽然传统的颅外入路已被证明能有效地切除这些肿瘤,但涉及使用内窥镜的微创入路有可能减少脑和神经的回缩,使切口最小化,并加速患者康复;然而,缺乏合适的病例选择和大系列结果。
方法
作者根据嗅觉的存在与否以及肿瘤的解剖范围,制定了一种选择眶上额微创颅切开术(SKM)治疗嗅沟脑膜瘤或扩大经鼻内镜入路(EEA)治疗鞍结节(TS)或蝶骨平台脑膜瘤的算法。对于不适合任何一种方法的病例,采用标准的颅外入路。作者描述了 7 组患者的大体全切除(GTR)率、嗅觉结果和视觉结果,以及并发症,对算法的例外情况也进行了讨论。
结果
57 例前颅底脑膜瘤患者的 57 例脑膜瘤,平均肿瘤体积为 14.7 ± 15.4cm(范围 2.2-66.1cm),平均随访时间为 42.2 ± 37.1 个月(范围 2-144 个月)。19 例嗅沟脑膜瘤患者中,10 例嗅觉保存,行 SKM,嗅觉保存率为 60%。9 例无嗅觉患者中,8 例筛板侵犯,行 SKM 联合 EEA(n=3)、额骨瓣开颅术(n=3)或 EEA(n=2),1 例无嗅觉和筛板侵犯的患者行 SKM。GTR 率为 94.7%。38 例 TS/PS 脑膜瘤中,根据算法治疗 36 例。这 36 例脑膜瘤中,30 例行 EEA,6 例行开颅术。GTR 率为 97.2%,无视力恶化,1 例发生脑脊液漏,经腰椎引流治愈。2 例根据算法不适合 EEA 的肿瘤患者仍行 EEA:1 例实现 GTR,另 1 例肿瘤残留,9 年后行开颅手术切除。
结论
利用旨在保留嗅觉和视力的简单算法,并基于最大限度地使用微创入路和选择性使用颅外入路,作者发现可以为前颅底脑膜瘤取得极好的结果。
World Neurosurg. 2011-11-7
Neurosurgery. 2008-7
Front Neurol. 2025-6-13
Adv Tech Stand Neurosurg. 2024
Adv Tech Stand Neurosurg. 2024
Adv Tech Stand Neurosurg. 2024
Adv Tech Stand Neurosurg. 2024